What the White House knew about J&J’s vaccine woes — Harris headlines vaccine outreach initiative — Today: New subsidies hit Obamacare markets

From: POLITICO Pulse - Thursday Apr 01,2021 02:03 pm
Presented by Blue Cross Blue Shield Association: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Apr 01, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Adam Cancryn

Presented by

With Rachel Roubein

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Quick Fix

The Biden administration knew two weeks ago that Johnson & Johnson's vaccine production had run into yet more obstacles.

Vice President Kamala Harris will headline the launch of the administration’s grassroots vaccine education campaign today.

— Shoppers on the federal Obamacare insurance exchange can begin signing up for new financial help today, thanks to subsidies passed in Democrats’ latest Covid aid package.

WELCOME TO THURSDAY PULSE — where despite the date, this is no joke: PULSE has a big announcement coming in this space in tomorrow's issue. Until then, tips to acancryn@politico.com.

A message from Blue Cross Blue Shield Association:

Blue Cross and Blue Shield companies have committed more than $7 billion to help the nation address the COVID-19 outbreak, by providing premium relief, enhancing access to telehealth and investing to support people in need. Learn more.

 
Driving the Day

BIDEN’s J&J VACCINE PUSH STUMBLES AGAIN — Senior Biden health officials knew two weeks ago that a contractor’s vaccine production problems threatened to delay delivery of critical vaccine doses.

But on Wednesday, the extent of the difficulties became clear, POLITICO’s Erin Banco, Sarah Owermohle and Rachel Roubein report: A mix-up by the contractor, Emergent BioSolutions, caused it to waste 15 million J&J vaccine doses.

The mistake is just the latest snag for a vaccine the Biden administration had once touted as crucial to inoculating hard-to-reach communities and accelerating the overall immunization drive.

J&J itself ran into production issues earlier this year and just barely met its goal of shipping 20 million doses to the U.S. by the end of March. Now, it’s unclear whether the company will be able to hit its next delivery milestone: 100 million doses by June.

Biden officials have since instructed J&J to begin supervising Emergent’s production process. Still, the distribution of doses to states is likely to be patchy over the next several weeks, and future shipments could be further delayed.

And that’s not all: Also on Wednesday, a whistleblower confirmed to Sarah that a Merck factory now being retrofitted to produce J&J doses was the subject of a complaint about safety and hygiene violations.

In the complaint, a former FDA safety officer said that FDA inspection officials downplayed a range of safety hazards at the plant, including that employees were "soiling their uniforms rather than taking bathroom breaks.” The former FDA officer also accused Merck of destroying evidence.

Merck agreed in March to help J&J bottle millions of vaccine doses starting as early as May, with plans to start producing the vaccine itself in the second half of the year.

HARRIS HEADLINES VACCINE OUTREACH INITIATIVE— The vice president will lead a meeting this morning with founding members of the fledgling Covid-19 Community Corps, the next step in the administration’s vaccine outreach effort.

The group, meant to amplify the administration’s messaging and help combat vaccine skepticism, includes 275 organizations and people representing various industries and communities. Among the notable participants: the American Medical Association, Planned Parenthood, religious and veterans groups, major sports leagues like the MLB and NFL, labor unions and a range of rural, Latino, Black, Asian and Native American organizations.

— Surgeon General VIVEK MURTHY, who will co-chair the initiative alongside several other top health officials, will appear alongside Harris today. It’s his first major assignment since his confirmation last week.

— HHS is also debuting a series of TV ads targeted to various demographics that encourage people to get vaccinated. The department is also releasing pro-vaccine “social frames” that people can overlay onto their Facebook profile pictures.

 

JOIN THE CONVERSATION, SUBSCRIBE TO “THE RECAST” Power dynamics are shifting in Washington, and more people are demanding a seat at the table, insisting that all politics is personal and not all policy is equitable. “The Recast” is a new twice-weekly newsletter that breaks down how race and identity are recasting politics, policy and power in America. Get fresh insights, scoops and dispatches on this crucial intersection from across the country and hear from new voices that challenge business as usual. Don’t miss out on our latest newsletter, SUBSCRIBE NOW. Thank you to our sponsor, Intel.

 
 
Obamacare

NEW SUBSIDIES HIT THE OBAMACARE MARKETS — The new Obamacare subsidies available starting today are more generous for low-income customers but are being extended for the first time to middle-income Americans, Rachel writes. Biden last week also gave people another three months to purchase coverage, extending the open enrollment window until Aug. 15.

— HHS will double its outreach budget for the enrollment season, which will fund new ads touting the expanded subsidies. The campaign will run on TV and over digital, email, radio and streaming video platforms.

 

Advertisement Image

 
Coronavirus

WHEN IS A SURGE A ‘SURGE’? — A sharp rise in coronavirus cases has Biden officials struggling with how to deliver two simultaneous messages to the American public: The nation is closer than ever to ending the pandemic, but the virus still poses an imminent danger.

As Erin and Sarah report, the messaging challenge has spurred debate inside the administration over whether the nation is seeing a Covid “surge,” and how to balance the optimism of accelerating vaccinations with the reality that new infections could quickly outpace them.

— What is clear: Cases over a seven-day average have risen by 13 percent from last week, higher even than when CDC Director Rochelle Walensky on Monday warned of “impending doom.” Roughly 40 percent of counties now qualify as having high community transmission.

— But unlike during earlier waves, the administration now has vaccines that are being rapidly deployed around the country. That’s eased some of the concerns among Biden officials, though they’ve remained adamant that people stick to public health precautions in hopes of fully snuffing out a potential resurgence.

FDA GREENLIGHTS MORE COVID SCREENING TESTS — The agency is authorizing another batch of at-home Covid tests that can be used to repeatedly screen asymptomatic people, POLITICO’s David Lim reports.

The move expands the suite of tests available to help reopen schools and workplaces, allowing for people to frequently test themselves for Covid and isolate quickly if they’re positive.

— What got authorized: Three different versions of Abbott’s BinaxNOW test, including one that can be used over-the-counter at home and second cleared for at-home use with a telehealth proctor. An iteration of Quidel’s QuickVue test can now be sold over the counter for at-home testing, too. And BD’s Veritor System was authorized for use in point-of-care settings with a prescription.

NIH TESTING MODERNA VACCINE AGAINST COVID VARIANT — The NIH is enrolling adults in an early-phase clinical trial for a Moderna vaccine that targets a more contagious Covid variant first found in South Africa, David reports.

The trial will include about 210 participants, 60 of whom were also part of Moderna’s original Covid vaccine study. Half of those 60 will get a booster shot containing a vaccine against the South African variant, and the rest will get a mixed booster containing the original shot and the new formulation. The unvaccinated volunteers will be assigned varying vaccination schedules.

Names in the News

BEN SMITH joins the Federation of American Hospitals. Smith will be the for-profit hospital group’s director of digital media and communications. He was previously the digital fundraising manager for RedPeg Marketing.

A message from Blue Cross Blue Shield Association:

Blue Cross and Blue Shield companies nationwide are using data and local relationships to help vaccinate millions of at-risk seniors living in underserved and vulnerable communities where COVID-19 vaccines are most inequitable. See how.

 
What We're Reading

For The Atlantic, Timothy Noah lays out why D.C. is lagging so far behind in vaccinating its residents.

Indiana’s Medicaid expansion — which included “personal responsibility” provisions implemented under then-Gov. Mike Pence — has proven no better at improving health and access to care than more straightforward expansions in other states, Kaiser Health News’ Phil Galewitz reports.

Slate’s Will Saletan argues that much of the criticism of former Trump White House Covid coordinator Deborah Birx was misguided, and didn’t give enough credit to her efforts to influence the response.

 

TUNE IN TO GLOBAL TRANSLATIONS: Our Global Translations podcast, presented by Citi, examines the long-term costs of the short-term thinking that drives many political and business decisions. The world has long been beset by big problems that defy political boundaries, and these issues have exploded over the past year amid a global pandemic. This podcast helps to identify and understand the impediments to smart policymaking. Subscribe and start listening today.

 
 
 

Follow us on Twitter

Joanne Kenen @joannekenen

Adriel Bettelheim @abettel

Jason Millman @jasonmillman

Lauren Morello @lmorello_dc

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Susannah Luthi @SusannahLuthi

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Mohana Ravindranath @ravindranize

Rachel Roubein @rachel_roubein

Darius Tahir @dariustahir

Erin Banco @ErinBanco

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse